These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 17418569

  • 21. C-N bond formation under Cu-catalysis: synthesis and in vitro evaluation of N-aryl substituted thieno[2,3-d]pyrimidin-4(3H)-ones against chorismate mutase.
    Adepu R, Shiva Kumar K, Sandra S, Rambabu D, Rama Krishna G, Malla Reddy C, Kandale A, Misra P, Pal M.
    Bioorg Med Chem; 2012 Sep 01; 20(17):5127-38. PubMed ID: 22863527
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
    Manos-Turvey A, Bulloch EM, Rutledge PJ, Baker EN, Lott JS, Payne RJ.
    ChemMedChem; 2010 Jul 05; 5(7):1067-79. PubMed ID: 20512795
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of the secreted chorismate mutase from the pathogen Mycobacterium tuberculosis.
    Sasso S, Ramakrishnan C, Gamper M, Hilvert D, Kast P.
    FEBS J; 2005 Jan 05; 272(2):375-89. PubMed ID: 15654876
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
    Saxena S, Devi PB, Soni V, Yogeeswari P, Sriram D.
    J Mol Graph Model; 2014 Feb 05; 47():37-43. PubMed ID: 24316937
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB, Jogula S, Reddy AP, Saxena S, Sridevi JP, Sriram D, Yogeeswari P.
    Mol Inform; 2015 Feb 05; 34(2-3):147-59. PubMed ID: 27490037
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S, Zandberg WF, Mohan S, Ko M, Martinez-Gutierrez F, Partha SK, Sanders DA, Av-Gay Y, Pinto BM.
    Int J Antimicrob Agents; 2010 Oct 05; 36(4):364-8. PubMed ID: 20678902
    [Abstract] [Full Text] [Related]

  • 37. New molecular scaffolds for the design of Mycobacterium tuberculosis type II dehydroquinase inhibitors identified using ligand and receptor based virtual screening.
    Kumar A, Siddiqi MI, Miertus S.
    J Mol Model; 2010 Apr 05; 16(4):693-712. PubMed ID: 19816720
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C, Gau S, Lherbet C, Rodriguez F, Inard C, Pasca MR, Baltas M.
    Eur J Med Chem; 2011 Nov 05; 46(11):5524-31. PubMed ID: 21944473
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S, Abdullah M, Sriram D, Guruprasad L.
    J Biomol Struct Dyn; 2018 Sep 05; 36(12):3184-3198. PubMed ID: 28948866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.